Peter W Young1, Emily Zielinski-Gutierrez1, Joyce Wamicwe2, Irene Mukui2, Andrea A Kim3, Anthony Waruru1, Clement Zeh3, Mirjam E Kretzschmar4,5, Kevin M De Cock1. 1. Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Nairobi. 2. National AIDS & STI Control Programme, Ministry of Health, Kenya. 3. Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 4. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht. 5. Centre for Infectious Disease Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Abstract
OBJECTIVE: To compare alternative methods of adjusting self-reported knowledge of HIV-positive status and antiretroviral (ARV) therapy use based on undetectable viral load (UVL) and ARV detection in blood. DESIGN: Post hoc analysis of nationally representative household survey to compare alternative biomarker-based adjustments to population HIV indicators. METHODS: We reclassified HIV-positive participants aged 15-64 years in the 2012 Kenya AIDS Indicator Survey (KAIS) who were unaware of their HIV-positive status by self-report as aware and on antiretroviral treatment if either ARVs were detected or viral load was undetectable (<550 copies/ml) on dried blood spots. We compared self-report to adjustments for ARV measurement, UVL, or both. RESULTS: Treatment coverage among all HIV-positive respondents increased from 31.8% for self-report to 42.5% [95% confidence interval (CI) 37.4-47.8] based on ARV detection alone, to 42.8% (95% CI 37.9-47.8) when ARV-adjusted, 46.2% (95% CI 41.3-51.1) when UVL-adjusted and 48.8% (95% CI 43.9-53.8) when adjusted for either ARV or UVL. Awareness of positive status increased from 46.9% for self-report to 56.2% (95% CI 50.7-61.6) when ARV-adjusted, 57.5% (95% CI 51.9-63.0) when UVL-adjusted, and 59.8% (95% CI 54.2-65.1) when adjusted for either ARV or UVL. CONCLUSION: Undetectable viral load, which is routinely measured in surveys, may be a useful adjunct or alternative to ARV detection for adjusting survey estimates of knowledge of HIV status and antiretroviral treatment coverage.
OBJECTIVE: To compare alternative methods of adjusting self-reported knowledge of HIV-positive status and antiretroviral (ARV) therapy use based on undetectable viral load (UVL) and ARV detection in blood. DESIGN: Post hoc analysis of nationally representative household survey to compare alternative biomarker-based adjustments to population HIV indicators. METHODS: We reclassified HIV-positive participants aged 15-64 years in the 2012 Kenya AIDS Indicator Survey (KAIS) who were unaware of their HIV-positive status by self-report as aware and on antiretroviral treatment if either ARVs were detected or viral load was undetectable (<550 copies/ml) on dried blood spots. We compared self-report to adjustments for ARV measurement, UVL, or both. RESULTS: Treatment coverage among all HIV-positive respondents increased from 31.8% for self-report to 42.5% [95% confidence interval (CI) 37.4-47.8] based on ARV detection alone, to 42.8% (95% CI 37.9-47.8) when ARV-adjusted, 46.2% (95% CI 41.3-51.1) when UVL-adjusted and 48.8% (95% CI 43.9-53.8) when adjusted for either ARV or UVL. Awareness of positive status increased from 46.9% for self-report to 56.2% (95% CI 50.7-61.6) when ARV-adjusted, 57.5% (95% CI 51.9-63.0) when UVL-adjusted, and 59.8% (95% CI 54.2-65.1) when adjusted for either ARV or UVL. CONCLUSION: Undetectable viral load, which is routinely measured in surveys, may be a useful adjunct or alternative to ARV detection for adjusting survey estimates of knowledge of HIV status and antiretroviral treatment coverage.
Authors: Christine A Kelly; Paul C Hewett; Barbara S Mensch; Johanna C Rankin; Samuel L Nsobya; Samuel Kalibala; Pamela N Kakande Journal: Stud Fam Plann Date: 2014-03
Authors: Y K Kiros; H Elinav; A Gebreyesus; H Gebremeskel; J Azar; D Chemtob; H Abreha; D Elbirt; E Shahar; M Chowers; D Turner; Z Grossman; A Haile; R E Sutton; S L Maayan; D Wolday Journal: HIV Med Date: 2018-10-14 Impact factor: 3.180
Authors: Andrea A Kim; Irene Mukui; Peter W Young; Joy Mirjahangir; Sophie Mwanyumba; Joyce Wamicwe; Nancy Bowen; Lubbe Wiesner; Lucy Ng'ang'a; Kevin M De Cock Journal: AIDS Date: 2016-11-13 Impact factor: 4.177
Authors: Alyssa C Mooney; Chadwick K Campbell; Mary-Jane Ratlhagana; Jessica S Grignon; Sipho Mazibuko; Emily Agnew; Hailey Gilmore; Scott Barnhart; Adrian Puren; Starley B Shade; Teri Liegler; Sheri A Lippman Journal: AIDS Behav Date: 2018-07
Authors: Maria F Nardell; Oluwatomi Adeoti; Carson Peters; Bernard Kakuhikire; Caroline Govathson-Mandimika; Lawrence Long; Sophie Pascoe; Alexander C Tsai; Ingrid T Katz Journal: J Int AIDS Soc Date: 2022-03 Impact factor: 5.396